Back to Search
BRIAN MAURER, M.D.
M.D.
Orthopaedic Surgery Physician
NPI: 1225038532IndividualAccepts Medicare
Specialties, Licenses & Credentials
Adult Reconstructive Orthopaedic Surgery Physician
Orthopaedic Surgery — Adult Reconstructive Orthopaedic Surgery
Code: 207XS0114X
36082960(IL)
Orthopaedic Surgery PhysicianPrimary
Orthopaedic Surgery
Code: 207X00000X
036082960(IL)
CMS Specialties
PrimaryORTHOPEDIC SURGERY
Education
UNIVERSITY OF ILLINOIS COLLEGE OF MED (CHI/PEOR/ROCK/CHM-URB)
Class of 1991
Research & Publications (20)
Improved oral delivery of N-(4-hydroxyphenyl)retinamide with a novel LYM-X-SORB organized lipid complex.
PMID 17505011·Clin Cancer Res·2007
7-preclinical
Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
PMID 11106681·J Natl Cancer Inst·2000
8-other
Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functions in vitro and in vivo.
PMID 18774958·J Cell Mol Med·2009
7-preclinical
Oral fenretinide in biochemically recurrent prostate cancer: a California cancer consortium phase II trial.
PMID 19213668·Clin Genitourin Cancer·2009
3-trial
Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide.
PMID 19621427·Pediatr Blood Cancer·2009
5-case
Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists.
PMID 19492850·ACS Chem Biol·2009
8-other
Measurements of the diameters of the great arteries and semi-lunar valves of chick and mouse embryos.
PMID 19397746·J Microsc·2009
7-preclinical
Histone deacetylase 7, a potential target for the antifibrotic treatment of systemic sclerosis.
PMID 19404935·Arthritis Rheum·2009
8-other
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis.
PMID 18326784·FASEB J·2008
8-other
reCAPTCHA: human-based character recognition via Web security measures.
PMID 18703711·Science·2008
8-other
N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing.
PMID 18790777·Mol Cancer Ther·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 303 N WILLIAM KUMPF BLVD
PEORIA, IL 61605 - Phone
- (309) 676-5546
Quick Facts
- NPI
- 1225038532
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile